Results 321 to 330 of about 419,079 (384)
Some of the next articles are maybe not open access.
Combination Hepatitis A-Hepatitis B Vaccine
BioDrugs, 1997The adult formulation of this combination hepatitis A-hepatitis B vaccine contains 720 enzyme-linked immunosorbent assay units (EU) of formalin-inactivated hepatitis A virus strain HM175 and 20mug of recombinant DNA yeast-derived hepatitis B surface antigen adsorbed onto aluminium salts in 1ml for injection.
Julia A. Balfour, Antona J. Wagstaff
openaire +3 more sources
Vaccine, 1983
Abstract Hepatitis B is endemic in many African, Asian and Pacific countries causing much debilitation and death. The disease can lead to chronic cirrhosis and is closely associated with liver cell cancer. There are in the order of 200 million people that carry the virus and constitute a huge reservoir of infection.
openaire +3 more sources
Abstract Hepatitis B is endemic in many African, Asian and Pacific countries causing much debilitation and death. The disease can lead to chronic cirrhosis and is closely associated with liver cell cancer. There are in the order of 200 million people that carry the virus and constitute a huge reservoir of infection.
openaire +3 more sources
A review of hepatitis B vaccination
Expert Opinion on Drug Safety, 2003Hepatitis B is one of the most important infectious causes of acute and chronic liver disease both in the US and worldwide. In order to combat the life-threatening effects of hepatitis B infection, recombinant hepatitis B vaccines have been developed.
Arthur C. Zahalsky +2 more
openaire +3 more sources
Current Hepatitis Reports, 2006 Hepatitis B virus (HBV)infection is a major cause of chronic hepatitis and cirrhosis,with an estimated 350 million people worldwide infected with the virus.Despite continuing advances in antiviral therapy,a cure for chronic HBV infection is considered an elusive goal.Thus,primary prevention by immunization with HBV vaccines remains the most effective ...
Henry C. Bodenheimer +2 more
openaire +1 more source
Hepatitis B and A vaccines [PDF]
, 1989 Hepatitis has been recognized as a serious disease throughout recorded history. Outbreaks of jaundice came to be recognized over time as potentially infectious in nature. The confirmation of a viral aetiology to certain forms of hepatitis was established in the early 1940s in studies in human volunteers to whom hepatitis could be transmitted by a non ...
P. J. Provost, R. W. Ellis
openaire +1 more source
, 1988 The first results of active immunization against hepatitis B in humans were reported a little over 10 years ago (Maupas et al., 1976). Since then, several serum-derived hepatitis B (HB) vaccines have been proved safe, highly immunogenic and efficacious in various populations at risk (Stevens et al., 1984).
F. Tron +8 more
openaire +1 more source
, 1999 Hepatitis B virus (HBV) chronically infects 200–300 million people worldwide. The resulting acute and chronic disease that results from contact with these individuals or their blood is a leading cause of liver disease, including hepatocellular carcinoma, and mortality. In fact, HBV is second only to smoking as a cause of human cancers (1).
openaire +1 more source
Clinics in Liver Disease, 1999
On a global basis, the hepatitis B virus (HBV) is the most important vaccine-preventable liver disease. As a consequence, the development of vaccines for the prevention of HBV represents one of the major achievements of modern medicine. 34 Universal immunization against HBV has been adopted in over 80 countries.
openaire +2 more sources
On a global basis, the hepatitis B virus (HBV) is the most important vaccine-preventable liver disease. As a consequence, the development of vaccines for the prevention of HBV represents one of the major achievements of modern medicine. 34 Universal immunization against HBV has been adopted in over 80 countries.
openaire +2 more sources
2017
Hepatitis A is a liver disease caused by the hepatitis A virus (HAV). The incubation period of hepatitis A is usually 14–28 days. Symptoms of hepatitis A range from mild to severe, and can include fever, malaise, loss of appetite, diarrhea, nausea, abdominal discomfort, dark-colored urine, and jaundice (a yellowing of the skin and whites of the eyes ...
openaire +2 more sources
Hepatitis A is a liver disease caused by the hepatitis A virus (HAV). The incubation period of hepatitis A is usually 14–28 days. Symptoms of hepatitis A range from mild to severe, and can include fever, malaise, loss of appetite, diarrhea, nausea, abdominal discomfort, dark-colored urine, and jaundice (a yellowing of the skin and whites of the eyes ...
openaire +2 more sources